Ryman Healthcare PE Ratio 2024-2024 | RYHTY
Current and historical p/e ratio for Ryman Healthcare (RYHTY) from 2024 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Ryman Healthcare PE ratio as of June 27, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Ryman Healthcare PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2025-06-26 | 6.68 | 0.00 | |
2024-09-30 | 14.25 | 0 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.919B | $0.452B |
Ryman Healthcare Limited develops, owns and operates integrated retirement villages, rest homes and hospitals for the elderly principally in New Zealand and Australia. Ryman Healthcare Limited is based in Christchurch, New Zealand. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $144.179B | 27.04 |
CVS Health (CVS) | United States | $86.198B | 10.71 |
Elevance Health (ELV) | United States | $84.314B | 10.88 |
Cencora (COR) | United States | $57.484B | 20.00 |
DiDi Global (DIDIY) | China | $23.485B | 24.95 |
Natera (NTRA) | United States | $22.963B | 0.00 |
Labcorp Holdings (LH) | United States | $21.509B | 17.45 |
BioMerieux (BMXMF) | France | $16.861B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $14.205B | 0.00 |
Solventum (SOLV) | United States | $12.912B | 13.67 |
CochLear (CHEOY) | Australia | $12.870B | 0.00 |
ICON (ICLR) | Ireland | $11.851B | 11.02 |
Revvity (RVTY) | United States | $11.644B | 20.04 |
Viatris (VTRS) | United States | $10.704B | 3.68 |
Avantor (AVTR) | United States | $9.363B | 13.60 |
HealthEquity (HQY) | United States | $9.068B | 39.72 |
Medpace Holdings (MEDP) | United States | $8.818B | 23.42 |
Sonic Healthcare (SKHHY) | Australia | $8.465B | 0.00 |
Charles River Laboratories (CRL) | United States | $7.445B | 14.59 |
Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
Bausch + Lomb (BLCO) | Canada | $4.269B | 25.15 |
BrightSpring Health Services (BTSG) | United States | $4.058B | 37.23 |
Sotera Health (SHC) | United States | $3.225B | 18.32 |
Surgery Partners (SGRY) | United States | $2.781B | 36.17 |
Alignment Healthcare (ALHC) | United States | $2.722B | 0.00 |
Concentras Parent (CON) | United States | $2.652B | 15.33 |
Organon (OGN) | United States | $2.594B | 2.76 |
GeneDx Holdings (WGS) | United States | $2.556B | 98.45 |
PACS (PACS) | United States | $1.958B | 0.00 |
Ardent Health (ARDT) | United States | $1.904B | 8.12 |
Progyny (PGNY) | United States | $1.840B | 40.49 |
Premier (PINC) | United States | $1.796B | 13.63 |
GoodRx Holdings (GDRX) | United States | $1.761B | 35.21 |
Teladoc Health (TDOC) | United States | $1.412B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.181B | 0.00 | |
Pediatrix Medical (MD) | United States | $1.171B | 8.91 |
CareDx (CDNA) | United States | $1.074B | 16.77 |
Agilon Health (AGL) | United States | $0.956B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $0.806B | 7.54 |
Nutex Health (NUTX) | United States | $0.658B | 9.96 |
LifeMD (LFMD) | United States | $0.615B | 0.00 |
Embecta (EMBC) | United States | $0.542B | 3.65 |
InnovAge Holding (INNV) | United States | $0.532B | 0.00 |
Enhabit (EHAB) | United States | $0.482B | 39.62 |
Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
SBC Medicals (SBC) | United States | $0.464B | 0.00 |
Omada Health (OMDA) | $0.460B | 0.00 | |
Sonida Senior Living (SNDA) | United States | $0.459B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.312B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.249B | 0.00 |
Beauty Health (SKIN) | United States | $0.244B | 0.00 |
So-Young (SY) | China | $0.209B | 0.00 |
Oncology Institute (TOI) | United States | $0.200B | 0.00 |
DocGo (DCGO) | United States | $0.172B | 28.17 |
Pheton Holdings (PTHL) | China | $0.115B | 0.00 |
Insight Molecular Diagnostics (IMDX) | United States | $0.096B | 0.00 |
KindlyMD (NAKA) | United States | $0.089B | 0.00 |
Sera Prognostics (SERA) | United States | $0.075B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
ModivCare (MODV) | United States | $0.051B | 0.00 |
Biodesix (BDSX) | United States | $0.041B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.033B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.005B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
INVO Fertility (IVF) | United States | $0.002B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |